IC
PACB icon

IEQ Capital’s Pacific Biosciences PACB Stock Holding History

IEQ Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
123,782
+11,084
+10% +$16.1K ﹤0.01% 1823
2026
Q1 		$149K Buy
+112,698
New +$202K ﹤0.01% 1750
2025
Q4 		– Sell
-11,154
Closed -$14.3K – 1962
2025
Q3 		$14.3K Hold
11,154
– – ﹤0.01% 1827
2025
Q2 		$13.8K Sell
11,154
-270
-2% -$312 ﹤0.01% 1801
2025
Q1 		$13.5K Hold
11,424
– – ﹤0.01% 1594
2024
Q4 		$20.9K Hold
11,424
– – ﹤0.01% 1319
2024
Q3 		$19.4K Hold
11,424
– – ﹤0.01% 1149
2024
Q2 		$15.7K Sell
11,424
-47
-0.4% -$95 ﹤0.01% 997
2024
Q1 		$43K Buy
11,471
+47
+0.4% +$275 ﹤0.01% 952
2023
Q4 		$112K Hold
11,424
– – ﹤0.01% 881
2023
Q3 		$95.4K Hold
11,424
– – ﹤0.01% 894
2023
Q2 		$152K Hold
11,424
– – ﹤0.01% 823
2023
Q1 		$132K Hold
11,424
– – ﹤0.01% 841
2022
Q4 		$93.4K Hold
11,424
– – ﹤0.01% 773
2022
Q3 		$66K Hold
11,424
– – ﹤0.01% 816
2022
Q2 		$50K Hold
11,424
– – ﹤0.01% 784
2022
Q1 		$104K Buy
+11,424
New +$132K ﹤0.01% 790

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IEQ Capital's PACB Position: Q2 2026 in Review

IEQ Capital increased its Pacific Biosciences (PACB) stake by 9.8% in Q2 2026, buying an estimated $16.1K and bringing the position to 123,782 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

IEQ Capital first reported a position in PACB in Q1 2022 and has held it in 17 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • IEQ Capital held 123,782 shares of Pacific Biosciences worth $208K as of Q2 2026.
  • IEQ Capital bought 11,084 Pacific Biosciences shares in Q2 2026, an estimated $16.1K.
  • Pacific Biosciences made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1823 holding.
  • IEQ Capital first reported a position in Pacific Biosciences in Q1 2022 and has held it in 17 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.